🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a prospective, single-arm, multicenter exploratory clinical s...
Status
Not Yet Recruiting
Location
Jiangsu Cancer Hospital
Start Date
2026-05-30
Trial ID
NCT07446387
Treatments Being Tested
The goal of this prospective, single-arm, multi-center Phase II clinical tr...
Status
Recruiting
Location
Nanfang Hospital of Southern Medical University
Start Date
2025-12-25
Trial ID
NCT07327788
The study aims to evaluate the efficacy and safety of the QL1706 combinatio...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-07-25
Trial ID
NCT07045805
Treatments Being Tested
This single-arm, open-label, Phase II study assesses first-line QL1706 + be...
Status
Not Yet Recruiting
Location
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing 100021
Start Date
2025-08-01
Trial ID
NCT07083375
Treatments Being Tested
This is a single-center, single-arm clinical study to evaluate the efficacy...
Status
Not Yet Recruiting
Location
Fudan university cancer hospital
Start Date
2026-07
Trial ID
NCT07663513
Treatments Being Tested
This study aims to observe and evaluate the efficacy and safety of Iparomli...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-09-01
Trial ID
NCT07769853
Treatments Being Tested
The goal of this clinical trial is to evaluate QL1706 plus bevacizumab with...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-08
Trial ID
NCT07134413
Treatments Being Tested
This study is a single arm, phase II multicenter clinical trial to evaluate...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-07-01
Trial ID
NCT07035808
The goal of this Phase II clinical trial (The PHOENIX Study) is to evaluate...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-01-31
Trial ID
NCT07416058
Treatments Being Tested